Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

<< Previous
Bullboard Posts
Next >>
Post by Hopeforthebeston May 29, 2024 5:15pm
127 Views
Post# 36063152

Q1 - 2024

Q1 - 2024 Reduced sales, reduced margins, increased costs, increased lost$$$$ in Q1-2024 compared to Q1 - 2023. at this rate both Aezs and zo will be out of cash by mid 2025 .his si what a gagnon run set of companies bring you.
czo heading towards bankruptcy, Aezs near bankruptcy, Juvenite lready bankrupt except for payroll support through Czo.
gagnon pulls more than a $1,000,000.00 per year and this is the result.
Buy the way PGX 5l was suppose to be up and running by end of 2023 and 6 months later we are still waiting, hell we don't even have Health canada approval which could take years. 
What joke.
<< Previous
Bullboard Posts
Next >>